Active-duty US soldiers to receive psychedelic drugs for PTSD next year

Hope that sessions of MDMA-assisted therapy could help soldiers fight longer by helping them process trauma

As the war on drugs approaches its end, a new doctrine could soon take hold: psychedelic drugs for active-duty soldiers suffering from PTSD.

In two studies funded by the Department of Defense (DoD), 186 service personnel with PTSD will likely next year undergo multiple sessions of MDMA-assisted therapy.